01—Abstract
Summary
Summary of the 8-K filed November 7, 2024. Cited figures are marked; the original filing is the authoritative source.
NVIDIA Corporation announced a significant change to its Board of Directors with the appointment of Dr. Ellen Ochoa, effective November 7, 2024.
This appointment increases the size of the Board from twelve to thirteen members. Dr. Ochoa, a former astronaut and distinguished figure in STEM, is expected to contribute valuable expertise to NVIDIA's governance. Her addition signals a potential enhancement in the company's strategic oversight and corporate governance practices.
In connection with her appointment, Dr. Ochoa will receive initial equity grants, including restricted stock units vesting over three years and a pro-rated annual grant vesting in May 2025, along with a pro-rated annual cash retainer. These compensation arrangements are standard for new board members and are designed to align her interests with those of the company and its shareholders. Investors should note this expansion of the board as a step towards potentially broadening the diverse perspectives and experiences guiding NVIDIA's future.
02—Key points
Key Highlights
- NVIDIA appointed Dr. Ellen Ochoa to its Board of Directors, effective November 7, 2024.
- The Board size has been increased from twelve to thirteen directors.
- Dr. Ochoa is expected to be appointed to the Nominating and Corporate Governance Committee.
- Dr. Ochoa will receive an initial equity grant of 1,848 restricted stock units vesting over three years.
- A pro-rated annual equity grant of 1,321 restricted stock units will vest on May 21, 2025.
- She was granted a pro-rated annual cash retainer of $53,800, payable starting November 7, 2024.
- An indemnity agreement has been entered into with Dr. Ochoa.
03—Questions
Frequently Asked Questions
Who is Dr. Ellen Ochoa and why is her appointment significant?
Dr. Ellen Ochoa is a former astronaut and a highly respected figure in the fields of science, technology, engineering, and mathematics (STEM). Her appointment to NVIDIA's Board of Directors is significant as it brings a wealth of experience and diverse perspective to the company's governance and strategic decision-making. Her background may particularly benefit NVIDIA in areas related to innovation, technology, and potentially space exploration applications.
What is the impact of increasing the Board size?
Increasing the Board size from twelve to thirteen directors allows for the inclusion of more expertise and potentially a broader range of viewpoints. This can strengthen the Board's oversight capabilities, improve strategic discussions, and enhance corporate governance by ensuring diverse representation and specialized knowledge.
What are the financial implications of Dr. Ochoa's appointment for NVIDIA?
The financial implications are primarily related to Dr. Ochoa's compensation, which includes equity grants and a cash retainer. These are standard arrangements for board members and are designed to align her incentives with shareholder value. The total cost is expected to be manageable within NVIDIA's operational budget and is an investment in experienced board leadership. Specific details on vesting schedules and payment dates are provided in the filing.
What does it mean that Dr. Ochoa will be granted restricted stock units (RSUs)?
Restricted Stock Units (RSUs) are a form of equity compensation. Dr. Ochoa will receive these units, which represent the right to receive NVIDIA stock at a future date, typically after a vesting period. The vesting schedule of her grants (semi-annually over three years and a pro-rated annual grant vesting in May 2025) indicates NVIDIA's commitment to long-term alignment between Dr. Ochoa's service and the company's performance and stock value.
04—Continue